Worth Venture Partners, LLC - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 44 filers reported holding TRANSPHORM INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$2,558,057
-31.7%
1,152,278
+4.6%
1.52%
-25.6%
Q2 2023$3,745,712
+6.1%
1,101,680
+24.5%
2.04%
+18.5%
Q1 2023$3,530,360
-26.7%
884,8020.0%1.72%
-39.4%
Q4 2022$4,813,323
+5.0%
884,802
-2.9%
2.84%
+1.2%
Q3 2022$4,584,000
+67.5%
911,237
+45.8%
2.81%
+74.5%
Q2 2022$2,737,000
-36.5%
624,813
+2.6%
1.61%
-19.1%
Q1 2022$4,307,000609,1701.99%
Other shareholders
TRANSPHORM INC shareholders Q4 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,772,875$18,978,0005.90%
Worth Venture Partners, LLC 911,237$4,584,0002.81%
Kohlberg Kravis Roberts & Co. L.P. 22,675,980$114,060,0002.29%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 250,944$1,262,0001.37%
Soros Fund Management 673,991$3,390,0000.06%
Polar Asset Management Partners Inc. 709,700$3,570,0000.04%
AMERIPRISE FINANCIAL INC 3,805,595$19,142,0000.01%
Stratos Wealth Partners, LTD. 30,000$151,0000.00%
FMR LLC 886$4,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,801$54,0000.00%
View complete list of TRANSPHORM INC shareholders